Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

View:
Post by biorun on Feb 09, 2022 2:22pm

0.27

This seems to be a key resistance point. Last time was Oct 14 when we hit 0.27 level, and then nothing.... we are essentially back to the level (although a weak base), where we realized that their big milestone list was going to take longer to achieve - last summer.
Comment by BurningMoney5 on Feb 09, 2022 3:30pm
If a deal arrives soon, so let's hope within the next 4 weeks, the 0,27 CAD will not be an issue anymore. It's too much going on simultaneously, so many news could actually announce immediately. We all gave Howard and the team so much credit over the past years. It's time to deliver !!!!
Comment by biorun on Feb 09, 2022 3:44pm
If they can just get one or two good deals by end of May/summer, I think the tables could turn for good. My bets are with Top10 and Animal Health but there is an interesting piece on Anti-aging we can not forget. As well, Anti-viral too. We heard what PRC thinks of the first one, but there seems to be some new clues in the most recent February presentation on this second item that nobody is ...more  
Comment by jimmyhorizon on Feb 09, 2022 4:44pm
end of may? end of summer? the clinical trial was completed on March 31, 2021. due diligence was completed in september 2021. a contract should have been concluded by christmas, then sirona comes around the corner with linda. after the intervention of linda it would now be time to announce a deal and now it is being pushed out again 4 - 8 months? what is this talk about: "We heard what ...more  
Comment by biorun on Feb 09, 2022 6:04pm
Did the company announce they were pushing their plans out by 4-8 months? Or am I missing something?  I am simply saying that one or two good deals before May would be fundamentally good for shareholders and put the company on a completely different footing here to seriously drive the other pipelines, which for me are also equal or bigger hitters. IF the situation turns out to be as ...more  
Comment by navajojoe on Feb 09, 2022 8:35pm
This post has been removed in accordance with Community Policy
Comment by biorun on Feb 09, 2022 9:12pm
its not like we have investment analyst reports to look at and comment on. the last half decent analysis was from seeking alpha many moons ago. one can only presume that some research was at least done with industry or consultant experts when coming up with numbers. I have spoken with some industry people myself and royalties typically range from 4 to 12%, and if a top 10 is involved then the ...more  
Comment by jimmyhorizon on Feb 10, 2022 1:17am
what do you mean wexi: "We heard what PRC thinks of the first one, but there seems to be some new clues in the most recent february presentation on this second item that nobody is talking about."? "In final negotiations with potential partner for global rights; discussions with further interested parties" on page 12 of feb investor presentation? is it?
Comment by forhandlaren on Feb 10, 2022 1:33am
The top-10 partner funded the clinical trial so it makes sense that this partner is the preferred when it comes down to a deal. But in order to put some pressure to get a decent deal one should make sure to talk with other parties and if it goes south with the first one you have other options already established. I think that the others ones in line will put up indicative offers, but partly ...more  
Comment by jimmyhorizon on Feb 10, 2022 2:58am
has the company ever communicated a negative development in a timely manner? sirona communication goes like this: the big breakthrough with the world's big players in giant markets is imminent. then time passes without results. many excuses are found: slow lawyers, big sluggish companies, restructuring processes at the partners, crazy long timelines (what otherwise takes 3-6 weeks, takes ...more  
Comment by biorun on Feb 10, 2022 7:32am
How do you jump from what I said to all this? I have no idea when 1067 top 10 will announce and neither would anyone here or elsewhere. For 1067, PRC said the deal looks "imminent" and that is all we have to go on. Obviously some element of the market is speculating- we closed yesterday at 0.27! The clues I was referring to relate to the updated info on the confirmation of number of ...more  
Comment by jimmyhorizon on Feb 10, 2022 8:04am
All good and good morning. how i jump on it? i'm probably damaged from years of sirona corporate communication. then you read way too much out of every reference or non-event. normally you don't believe a liar anymore. you have a big advantage wexi, you can be wrong 1000 times and only have to be right once. we will see. if it comes as it is insinuated, then we are all happy and you ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities